In the News
In the News
Depression is common during the transition to menopause, but which women are most at risk for major depressive disorder? Mary Sammel, PhD, co-authored a new study that shows those who experience multiple traumatic events early on are more than twice as likely, during perimenopause.
The latest Testosterone Trial results, published in JAMA and JAMA Internal Medicine, include findings on cognition, bone health, heart health and anemia. Susan Ellenberg, PhD, commented that the treatment is not likely to be a magic bullet for patients, but that it may lead to improvements for them in some areas—bone density, in particular.
The Testosterone Trials’ latest results, published in JAMA and JAMA Internal Medicine, show that testosterone treatment for men over age 65 who have low levels of the hormone offers some benefits and not others. Co-author Susan Ellenberg, PhD, commented, “I don’t think anybody would interpret these results as saying, ‘Wow, this is a fountain of youth.”
The Philadelphia Inquirer chronicles the research of Daniel Rader, MD, and Danish Saleheen, MD, into the role that cholesterol and triglycerides play in human biology—and how that in turn applies to clinical cardiology.
The hot flashes and night sweats of menopause don't play out the same for all women, new research shows. Mary Sammel, ScD, suggested in HealthDay that the findings could help women know what to expect in general. “The patterns are more varied than we thought,” Sammel said.
Current health laws may stop low-income patients from getting vital screenings for colon cancer, according to a commentary co-authored by Chyke A. Doubeni, MD, MPH.
The Perelman School of Medicine and The Children's Hospital of Philadelphia will co-direct a U.S. Centers for Disease Control and Prevention (CDC) Prevention Epicenter site to help develop and test new methods to prevent infections in health care. The Epicenter will be co-led by Ebbing Lautenbach, MD, MPH, MSCE, and Jeffrey Gerber, MD, PhD, MSCE.
Reuters reported on a recent study showing that people with psoriasis may be at increased risk of calcium buildup in the arteries – an indicator of heart disease risk – comparable to that of people with diabetes. Joel M. Gelfand, MD, MSCE, who was not involved in the research, was quoted.
The assessment of pain along with its treatment is being questioned as some worry the current approaches to measuring pain on a scale of 0 to 10 have contributed to the nation's prescription drug epidemic. John Farrar, MD, PhD, and Jeanmarie Perrone, MD, share their perspectives on the best ways to assess and treat pain.
Victims of violence are at relatively high risk of returning to the ER within two years of an initial visit, according to a recent Penn study. “Our findings highlight the potential for housing stability, behavioral-health and substance abuse programs to break cycles of violence," said senior author M. Kit Delgado, MD, MS.
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics.